A Faster Path for Generics?

Drug Access and Costs the Focus of a Busy News Week

Efforts to replace and repeal—or just repeal—the Affordable Care Act dominated the news cycle this week. But several less-noticed actions occurred that could impact drug access and cost, says IMF Chairman Dr. Brian Durie. Among them: a meeting led by new FDA commissioner Dr. Scott Gottlieb aimed at accelerating generic competition and a court ruling extending the patent on Takeda’s myeloma drug Velcade® to 2022. Read Dr. Durie’s blog.

Listen to a Replay of the Myeloma Updates 2017 Webinar: Best of ASCO/EHA/IMWG

Listen to a replay and download slides from the Myeloma Updates 2017 webinar. This webinar features updates from the three major medical meetings held in June 2017 – the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA), and the International Myeloma Working Group Summit (IMWG).

 

Register NOW for the IMF Regional Community Workshop in Kansas City, Kansas

The IMF Regional Community Workshop in Kansas City, Kansas, takes place on September 9th, 2017 from 9 AM CST / 3 PM CST. Registration is FREE, but seating is limited. The expert panel includes Craig Cole, MD (University of Michigan), Dr. Siddhartha Ganguly, MD, FACP (University of Kansas Cancer Center), Dr. Al-Ola Abdallah, MD (University of Kansas Cancer Center, Kansas City, KS) and a member of the IMF Nurse Leadership Board. 

 

Bake Sales, Barbecues, and Wine Tastings: Oh My! - Plan Your Summer FUNdraising Activity Now

Did you know that the IMF has staff members who can work with you to organize public awareness and fundraising events? In the spirit of summer, brainstorm with Suzanne Battaglia, the IMF’s Director of Member Events, about simple and stress-free ways to raise myeloma awareness. Bake Sale? Picnic? Garage Sale? Wine & Cheese Party? Backyard BBQ? Anything occasion you are already planning or would like to plan, we are ready to help you. Contact Suzanne at sbattaglia@myeloma.org!

Calling All Researchers: Submit Your Grant Applications!

The Brian D. Novis Research Grants honor the IMF’s founder Brian Novis, who died of multiple myeloma in July of 1992. The grants are awarded to researchers in the field of multiple myeloma and related disorders including SMM (smoldering multiple myeloma), MGUS (monoclonal gammopathy of undetermined significance), and immunoglobulin-derived amyloidosis. The 2018 grants will fund senior research projects with $80,000 and junior research projects with $50,000. Tuesday, August 1st, 2017, is the deadline for applications.

 

View Topline Research Videos from ASCO 2017

In this video, Dr. Noopur S. Raje (Massachusetts General Hopsital Cancer Center) discusses the impact of denosumab compared with zoledronic acid on renal function in the treatment of myeloma bone disease. View this video and other topline research videos from ASCO 2017.

 

Are routine skeletal survey X-rays still recommended?

In this week’s video, Dr. Brian GM Durie explains why a baseline skeletal survey may be helpful, but more sensitive imaging is more precise.

 

 


We Thank Our Sponsors: Amgen, Celgene Corporation, Genentech, Janssen Pharmaceuticals, and Takeda Oncology